Pyrimidone compound and pharmaceutically acceptable salts thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 11, 1990
Grant Date -
N/A
app pub date -
Dec 7, 1988
filing date -
Dec 7, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A pyrimidone compound or a pharmaceutically acceptable salt thereof such as a 5,6-di-substituted-2-[4-<3-(1-piperidinomethyl)-phenoxyl>-cis-2-butenylamino]-4-(1H)-pyrimidone or a 5,6-di-substituted-2-[4-<4-(1-piperidinomethyl)-pyridyl-2-oxy>-cis-2-butenylamino]-4-(1H)-pyrimidone or a pharmaceutically acceptable salt thereof is herein disclosed. Such a compound or a salt thereof simultaneously shows gastric acid secretion inhibiting effect and gastric mucous membrane protecting effect and is useful as medicine for treating gastric diseases such as medicine for inhibiting gastric acid secretion or that for treating digestive ulcers.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully